Notice of 2026 first extraordinary general meeting
Filed with HKEX · Stock code 2185 · · 3 pages · English
Shanghai Bio-heart Biological Technology Co., Ltd. 上海百心安生物技术股份有限公司 (A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock Code: 2185) NOTICE OF 2026 FIRST EXTRAORDINARY GENERAL MEETING NOTICE IS HEREBY GIVEN that the 2026 first extraordinary general meeting (the “EGM”) of Shanghai Bio-heart Biological Technology Co., Ltd. (the “Company”) will be held a
Shanghai Bio-Heart Biological Technology Co., Ltd. on 6ix
Earlier from Shanghai Bio-Heart Biological Technology
- Announcement pursuant to rule 13.51B(2) of the listing rules
- Voluntary announcement strategic cooperation agreement with shanghai shenqi medical technology co., ltd. to advance the commercialisation of the bioheart bioabsorbable rapamycin-eluting coronary stent system
- Articles of association
Later from Shanghai Bio-Heart Biological Technology
- Proposed appointment of independent non-executive director; and (2) notice of 2026 first extraordinary general meeting
- Proxy form for use at the 2026 first extraordinary general meeting to be held on October 9, 2026
- 2026 Interim report
- Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2026
- (1) Poll results of the 2026 first extraordinary general meeting held on October 9, 2026; (2) resignation of independent non-executive director; (3) appointment of independent non-executive director; and (4) change of composition of board committees
Follow Shanghai Bio-Heart Biological Technology into a list and get an email when it puts out news.
Follow Shanghai Bio-Heart Biological Technology